NCT02590250 - A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

December 16, 2015

Primary Completion Date

August 7, 2017

Study Completion Date

August 7, 2017

Conditions

Urinary IncontinenceOveractive Bladder

Interventions

BIOLOGICAL

botulinum toxin Type A

Botulinum toxin Type A treatment for Neurogenic Detrusor Overactivity or Overactive Bladder as per local standard of care in clinical practice.

Trial Locations (12)

Dr. Ram Manohar Lohia Hospital, New Delhi

Fortis Escorts Heart Institute, Okhla Road

Indian Spinal Injuries Centre, New Delhi

Christian Medical College & Hospital, Ludhiana

Bodyline Hospitals, Ahmedabad

Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, Mumbai

AMAI Charitable Trust's ACE Hospital and Research Centre, Pune

Inamdar Multispeciality Hospital, Pune

Global Hospital, Hyderabad

NU Hospitals, Padmanabha Nagar

Fortis Hospitals, Bengaluru

Christian Medical College and Hospital, Vellore